Vsicule biliaire : calculs, cholcystite (risque de classe + perte de poids rapide) Mme si le retatrutide na pas encore une monographie comme un mdicament commercialis, il est pertinent de connatre le risque de classe observ avec les GLP-1 RA : une mta-analyse (JAMA Internal Medicine) a trouv une association entre GLP-1 RA et augmentation du risque de maladies de la vsicule/biliaires, surtout doses leves, sur une dure plus longue et en indication perte de poids
Through telemedicine, a medical provider can offer convenient and affordable healthcare services to patients
The presenter emphasized the need for weight-inclusive, ethically grounded care that prioritizes safety and informed consent
procedure data or device delay, correlation between GLP-1s and other disease areas, patient journeys and primary research to generate the key insights needed so MedTech companies can plan and strategize with confidence
Nausea during the switch is possible but generally milder than when you first started semaglutide